Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about IL22: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
IL22 is a gene implicated in neurodegeneration research. Key relationships include: expressed in, causes, activates. Associated with Als, Atherosclerosis, Inflammation. Connected to 19 entities in the SciDEX knowledge graph.
| Gene Symbol | IL22 |
| Chromosome | 12q13 |
| Function | is a member of the IL-10 cytokine family, encoded by the IL22 gene located on chromosome 12q13 [1](https://www. |
| Primary Expression | the CNS: - Astrocytes: Produce IL22 in response to inflammation - Neurons: Express IL22R in some regions - Microglia: Respond to IL22 sign |
| Pathways | JAK-STAT pathway, MAPK pathway, PI3K |
| Ensembl ID | ENSG00000127353 |
| GeneCards | IL22 |
| Human Protein Atlas | IL22 |
| gene = IL22 | name = Interleukin 22 |
| ncbi_gene_id = 50616 | ensembl = ENSG00000127353 |
| Associated Diseases | Als |
| Interactions | CD4, IL31, IFNG, PVALB, MMP12, IL6R |
| KG Connections | 61 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
IL22["IL22"]
STAT3["STAT3"]
JAK["JAK"]
CD4["CD4+ T cells"]
IFNG["IFN-gamma"]
S100A8["S100A8"]
S100A9["S100A9"]
IL31["IL31"]
Inflammation["Inflammation"]
ALS["Amyotrophic Lateral Sclerosis"]
Atherosclerosis["Atherosclerosis"]
Differentiation["T cell Differentiation"]
Neurodegeneration["Neurodegeneration"]
CLDN1["CLDN1"]
BBB["Blood-Brain Barrier"]
STAT3 -->|"transcriptionally activates"| IL22
IL22 -->|"activates"| JAK
JAK -->|"phosphorylates"| STAT3
IL22 -->|"stimulates"| CD4
CD4 -->|"produces"| IL22
IFNG -->|"induces expression"| IL22
S100A8 -->|"co-expressed with"| IL22
IL22 -->|"upregulates"| S100A9
IL22 -->|"co-expressed with"| IL31
IL22 -->|"promotes"| Inflammation
IL22 -->|"contributes to"| ALS
IL22 -->|"associated with"| Atherosclerosis
IL22 -->|"regulates"| Differentiation
Inflammation -->|"leads to"| Neurodegeneration
ALS -->|"type of"| Neurodegeneration
CLDN1 -->|"barrier function"| BBB
IL22 -->|"affects"| CLDN1
style IL22 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px
style ALS fill:#ef5350,stroke:#000,stroke-width:2px
style Neurodegeneration fill:#ef5350,stroke:#000,stroke-width:2px
style Inflammation fill:#ef5350,stroke:#000,stroke-width:2px
style Atherosclerosis fill:#ef5350,stroke:#000,stroke-width:2px
style STAT3 fill:#4a1a6b,stroke:#000,stroke-width:2px
style JAK fill:#4a1a6b,stroke:#000,stroke-width:2px
style IFNG fill:#4a1a6b,stroke:#000,stroke-width:2px
style CD4 fill:#1b5e20,stroke:#000,stroke-width:2px
style Differentiation fill:#1b5e20,stroke:#000,stroke-width:2px| Target | Relation | Type | Str |
|---|---|---|---|
| Als | expressed_in | disease | 0.65 |
| Atherosclerosis | expressed_in | disease | 0.65 |
| Inflammation | expressed_in | disease | 0.65 |
| Als | causes | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| ALS | expressed_in | disease | 0.65 |
| IL31 | expressed_in | gene | 0.60 |
| S100A9 | expressed_in | gene | 0.60 |
| CD4 | activates | gene | 0.60 |
| CLDN1 | expressed_in | gene | 0.60 |
| S100A8 | expressed_in | gene | 0.60 |
| IL6R | associated_with | gene | 0.60 |
| MMP12 | associated_with | gene | 0.60 |
| IFNG | expressed_in | gene | 0.60 |
| PVALB | associated_with | gene | 0.60 |
| IL6R | interacts_with | gene | 0.60 |
| MMP12 | interacts_with | gene | 0.60 |
| PVALB | interacts_with | gene | 0.60 |
| LOR | expressed_in | gene | 0.60 |
| GENES | expressed_in | gene | 0.60 |
| Differentiation | expressed_in | pathway | 0.60 |
| JAK | causes | gene | 0.60 |
| RNA | expressed_in | gene | 0.60 |
| IL4R | expressed_in | gene | 0.60 |
| IL-13 | expressed_in | gene | 0.60 |
| Macrophage | therapeutic_target | cell_type | 0.60 |
| T Cell | therapeutic_target | cell_type | 0.60 |
| AND | expressed_in | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| Interleukin | expressed_in | protein | 0.60 |
| INFLAMMATION | expressed_in | gene | 0.60 |
| Il-1 | expressed_in | protein | 0.60 |
| Ca1 | expressed_in | brain_region | 0.55 |
| T Cell | expressed_in | cell_type | 0.55 |
| Macrophage | expressed_in | cell_type | 0.55 |
| IL31 | activates | gene | 0.50 |
| IFNG | activates | gene | 0.50 |
| CLDN1 | activates | concept | 0.50 |
| PVALB | activates | gene | 0.50 |
| MMP12 | activates | gene | 0.50 |
| Proteins | activates | protein | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| IFNG | expressed_in | gene | 0.60 |
| S100A8 | expressed_in | gene | 0.60 |
| CLDN1 | expressed_in | gene | 0.60 |
| GAIN | causes | gene | 0.60 |
| STAT3 | causes | gene | 0.60 |
| PVALB | associated_with | gene | 0.60 |
| S100A9 | expressed_in | gene | 0.60 |
| IL6R | associated_with | gene | 0.60 |
| CCL26 | expressed_in | gene | 0.60 |
| AHR | regulates | gene | 0.60 |
| INFLAMMATION | expressed_in | gene | 0.60 |
| INFLAMMATION | activates | gene | 0.60 |
| GENES | expressed_in | gene | 0.60 |
| GENES | associated_with | gene | 0.60 |
| IL-13 | expressed_in | gene | 0.60 |
| IL4R | expressed_in | gene | 0.60 |
| RNA | expressed_in | gene | 0.60 |
| S100A9 | activates | gene | 0.50 |
| S100A8 | activates | gene | 0.50 |
| IL6R | activates | gene | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||